PM360

NOVEMBER 29, 2022

Drug labels hold value for life sciences companies because they are rich, extensive documents that can be used across labeling, regulatory, safety, and medical affairs. Typically, a drug label refers to any information provided with prescription drugs, as requested by regulators such as the U.S.

Food and Drug Administration 98

Food and Drug Administration Competition Safety Pharmacology 98

Medgadget

MAY 2, 2023

While for other patients the possible adverse side effects from medication may prevent them from finding pharmacological therapies effective. During this time, two additional studies ended successfully and were published, further validating the clinical safety and effectiveness.

Side effects 87

Side effects Prescription Healthcare Healthcare 87

Pharmaceutical Technology

AUGUST 8, 2022

But the pharmacology to quantify adherence also depends on race, gender, weight, and other factors. While there haven’t been breakthrough digital pill approvals, the agency has made some strides in the broader digital therapeutics space, where prescription devices are used by patients with the help of a smartphone or tablet.

Food and Drug Administration 122

Food and Drug Administration FDA Medicine Patients 122

Quantified

JUNE 28, 2022

On the one hand, patient need for access and business need to restore and accelerate sales and prescription momentum have never been more critical. Equally, certification can support compliance, fair balance and consistent inclusion of important safety information.

Sales 52

Sales Pharma Training Management 52

Pharmaceutical Technology

OCTOBER 10, 2022

Despite the recognized need and demand for options to treat female sexual dysfunction, several safety and access issues associated with the use of available options. All this development comes in the backdrop of a wider sense of stigma against the use of pharmacologic options for female sexual function, says Kingsberg.

Pharmacology 59

Pharmacology Side effects FDA Safety 59

Pharmaceutical Technology

MARCH 16, 2023

However, health specialists refute most safety concerns for the use of drug classes as part of gender affirming care, citing years of research and care. With restricted access and reduced prescription of puberty blockers and hormone therapies, the impact on pharmaceutical companies manufacturing these therapies also remains unclear.

Ethics 144

Ethics Prescription Safety Healthcare 144